Focused Investors LLC lowered its position in Aetna Inc. (NYSE:AET) by 19.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 696,000 shares of the company’s stock after selling 167,600 shares during the period. Aetna accounts for 4.5% of Focused Investors LLC’s portfolio, making the stock its 11th largest position. Focused Investors LLC owned about 0.21% of Aetna worth $105,674,000 as of its most recent filing with the SEC.
Several other institutional investors have also made changes to their positions in the company. Guardian Life Insurance Co. of America raised its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the period. Concert Wealth Management Inc. raised its position in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares during the period. CAPROCK Group Inc. raised its position in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares during the period. Rehmann Capital Advisory Group raised its position in shares of Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock worth $298,000 after buying an additional 25 shares during the period. Finally, Geneva Advisors LLC raised its position in shares of Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock worth $330,000 after buying an additional 25 shares during the period. Institutional investors and hedge funds own 91.69% of the company’s stock.
Aetna Inc. (NYSE:AET) traded down 0.87% on Friday, hitting $154.45. The stock had a trading volume of 1,781,161 shares. The stock has a 50-day moving average of $154.81 and a 200-day moving average of $140.38. Aetna Inc. has a one year low of $104.59 and a one year high of $161.69. The company has a market cap of $51.29 billion, a PE ratio of 34.28 and a beta of 0.54.
Aetna (NYSE:AET) last announced its earnings results on Thursday, August 3rd. The company reported $3.42 EPS for the quarter, beating the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The business had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. During the same period in the prior year, the business posted $2.21 earnings per share. Aetna’s revenue was down 2.7% compared to the same quarter last year. Equities analysts expect that Aetna Inc. will post $9.55 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Focused Investors LLC Cuts Stake in Aetna Inc. (AET)” was first reported by BNB Daily and is the property of of BNB Daily. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.baseball-news-blog.com/2017/08/19/focused-investors-llc-sells-167600-shares-of-aetna-inc-aet-updated-updated-updated.html.
A number of equities analysts recently weighed in on the stock. UBS AG reiterated a “buy” rating and issued a $160.00 price objective (up from $147.00) on shares of Aetna in a research report on Wednesday, May 17th. Argus reiterated a “buy” rating and issued a $165.00 price objective (up from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. Morgan Stanley lifted their price objective on shares of Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research report on Thursday. Credit Suisse Group reiterated a “buy” rating and issued a $155.00 price objective on shares of Aetna in a research report on Wednesday, May 17th. Finally, Cleveland Research upgraded shares of Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Seven investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Aetna currently has an average rating of “Buy” and an average price target of $157.99.
In other news, EVP Margaret M. Mccarthy sold 27,028 shares of the company’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the sale, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.90% of the company’s stock.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.